REPL
Replimune Group·NASDAQ
--
--(--)
--
--(--)
REPL fundamentals
Replimune Group (REPL) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.95 (YoY -21.79%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.95
-21.79%
Report date
Aug 7, 2025
EPS
Actual | -0.43 | -0.44 | -0.46 | -0.44 | -0.41 | -0.53 | -0.56 | -0.57 | -0.6071 | -0.78 | -0.79 | -0.69 | -0.73 | -0.75 | -0.9 | -0.77 | -0.82 | -0.78 | -0.68 | -0.79 | -0.82 | -0.95 | |||||||
Forecast | -0.4475 | -0.4367 | -0.4389 | -0.4067 | -0.4082 | -0.4411 | -0.5133 | -0.5513 | -0.5938 | -0.6043 | -0.7522 | -0.7456 | -0.6544 | -0.7988 | -0.8134 | -0.8924 | -0.7681 | -0.857 | -0.8233 | -0.7219 | -0.708 | -0.7945 | |||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +3.91% | -0.76% | -4.81% | -8.19% | -0.44% | -20.15% | -9.10% | -3.39% | -2.24% | -29.07% | -5.03% | +7.46% | -11.55% | +6.11% | -10.65% | +13.72% | -6.76% | +8.98% | +17.41% | -9.43% | -15.82% | -19.57% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Replimune Group's latest dividend and current dividend yield?What is Replimune Group's gross profit margin?What does Replimune Group do and what are its main business segments?What guidance did Replimune Group's management provide for the next earnings period?What were the key takeaways from Replimune Group’s earnings call?What is the revenue and EPS growth rate for Replimune Group year over year?Did Replimune Group beat or miss consensus estimates last quarter?What factors drove the changes in Replimune Group's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
